Videos / Updated indications for the recombinant, adjuvanted RSV vaccine
In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.
This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.


Cardiovascular Risk and Fatty Liver Disease

Importance of Early & Effective Treatment of Mild to Moderate Acne

SGLT2s and Renal Protection

CV Medications – Practical Strategies to Improve Compliance

expert
Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital